Skip to main content
Clinical Trials/ACTRN12615000841572
ACTRN12615000841572
Not Yet Recruiting
N/A

The effect of respiratory muscle training to strengthen the inspiratory muscles after a pleurodesis for malignant pleural effusion

Dr Luke Garske0 sites36 target enrollmentAugust 13, 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Luke Garske
Enrollment
36
Status
Not Yet Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 13, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Luke Garske

Eligibility Criteria

Inclusion Criteria

  • 1\. Malignant Pleural Effusion (defined as fluid around lung caused by cancer infiltrating the pleura): diagnosed on basis of (a) pleural fluid cytology or biopsy, or (b) a large exudative pleural effusion with no other cause identified and disseminated extra\-thoracic malignancy.
  • 2\. Participants have undergone a pleurodesis 3 weeks prior to study entry. Pleurodesis may be either surgical (VATS or thoracoscopy) or closed chest tube pleurodesis.
  • 3\. No significant fluid re\-accumulation on clinical assessment 3 weeks after a pleurodesis.

Exclusion Criteria

  • Expected survival \< 3 months
  • WHO performance status 3 or 4
  • Body mass index less than 19 or greater than 40
  • Hypoxia requiring long term oxygen therapy
  • Severe cardiac or pulmonary disease causing dyspnea
  • Neurologic disease which may affect respiratory muscle strength, or co\-operation with testing
  • Long term steroid therapy
  • Significant chest pain which might interfere with breathing tests and training
  • Pleural tumour greater than 20 mm thickness on CT chest
  • Recent pneumothorax

Outcomes

Primary Outcomes

Not specified

Similar Trials